Cargando…

A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation

Patient: Female, 46-year-old Final Diagnosis: Invasive mole Symptoms: Bleeding • vaginal bleeding Medication: — Clinical Procedure: Curettage • hysterectomy Specialty: Obstetrics and Gynecology • Oncology OBJECTIVE: Rare disease BACKGROUND: Gestational trophoblastic disease (GTD) is a spectrum of di...

Descripción completa

Detalles Bibliográficos
Autores principales: Harsono, Ali Budi, Hidayat, Yudi Mulyana, Winarno, Gatot Nyarumenteng A., Nisa, Aisyah Shofiatun, Alkaff, Firas Farisi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216494/
https://www.ncbi.nlm.nih.gov/pubmed/34127641
http://dx.doi.org/10.12659/AJCR.931156
_version_ 1783710429694918656
author Harsono, Ali Budi
Hidayat, Yudi Mulyana
Winarno, Gatot Nyarumenteng A.
Nisa, Aisyah Shofiatun
Alkaff, Firas Farisi
author_facet Harsono, Ali Budi
Hidayat, Yudi Mulyana
Winarno, Gatot Nyarumenteng A.
Nisa, Aisyah Shofiatun
Alkaff, Firas Farisi
author_sort Harsono, Ali Budi
collection PubMed
description Patient: Female, 46-year-old Final Diagnosis: Invasive mole Symptoms: Bleeding • vaginal bleeding Medication: — Clinical Procedure: Curettage • hysterectomy Specialty: Obstetrics and Gynecology • Oncology OBJECTIVE: Rare disease BACKGROUND: Gestational trophoblastic disease (GTD) is a spectrum of disorders consisting of premalignant (ie, complete [CHM] and partial hydatidiform moles [PHM]) and malignant conditions (ie, invasive moles, choriocarcinoma, placental site trophoblastic tumors, and epithelioid trophoblastic tumor). If GTD persists after initial treatment and has persistent elevated beta human chorionic gonadotropin (β-hCG), it is referred to as post-molar gestational trophoblastic neoplasia (pGTN). To date, there is no detailed information regarding how fast invasive moles can develop from CHM. However, the risk of developing any pGTN from CHM is rare within 1 month and is greatest in the first 12 months after evacuation, with most cases presenting within 6 months. CASE REPORT: We present a case of a 46-year-old primigravida woman with rapid transformation of an invasive mole. In the beginning, the patient had a chief concern of a uterus size greater than the gestational dates. Laboratory evaluation showed high β-hCG serum level (>300 000 mIU/mL), and ultrasonography evaluation revealed a hydatidiform mole. Suction evacuation and curettage procedures were then performed. Pathology evaluation afterwards revealed a complete hydatidiform mole without any sign of malignancy. Twenty-two days afterwards, the patient came to the emergency room with vaginal bleeding. β-hCG serum level was high (53 969 mIU/mL), and ultrasonography examination showed the presence of fluid filling the uterine cavity. The patient was then diagnosed with GTN, and hysterectomy was chosen as the treatment of choice. After the surgery, her β-hCG serum level gradually reverted back to normal. CONCLUSIONS: Invasive moles can develop less than 1 month after suction evacuation and curettage procedure for CHM. Serial β-hCG serum level evaluation according to the guideline should be performed to prevent late diagnosis, which could lead to the development of metastasis and worsen the prognosis.
format Online
Article
Text
id pubmed-8216494
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-82164942021-07-02 A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation Harsono, Ali Budi Hidayat, Yudi Mulyana Winarno, Gatot Nyarumenteng A. Nisa, Aisyah Shofiatun Alkaff, Firas Farisi Am J Case Rep Articles Patient: Female, 46-year-old Final Diagnosis: Invasive mole Symptoms: Bleeding • vaginal bleeding Medication: — Clinical Procedure: Curettage • hysterectomy Specialty: Obstetrics and Gynecology • Oncology OBJECTIVE: Rare disease BACKGROUND: Gestational trophoblastic disease (GTD) is a spectrum of disorders consisting of premalignant (ie, complete [CHM] and partial hydatidiform moles [PHM]) and malignant conditions (ie, invasive moles, choriocarcinoma, placental site trophoblastic tumors, and epithelioid trophoblastic tumor). If GTD persists after initial treatment and has persistent elevated beta human chorionic gonadotropin (β-hCG), it is referred to as post-molar gestational trophoblastic neoplasia (pGTN). To date, there is no detailed information regarding how fast invasive moles can develop from CHM. However, the risk of developing any pGTN from CHM is rare within 1 month and is greatest in the first 12 months after evacuation, with most cases presenting within 6 months. CASE REPORT: We present a case of a 46-year-old primigravida woman with rapid transformation of an invasive mole. In the beginning, the patient had a chief concern of a uterus size greater than the gestational dates. Laboratory evaluation showed high β-hCG serum level (>300 000 mIU/mL), and ultrasonography evaluation revealed a hydatidiform mole. Suction evacuation and curettage procedures were then performed. Pathology evaluation afterwards revealed a complete hydatidiform mole without any sign of malignancy. Twenty-two days afterwards, the patient came to the emergency room with vaginal bleeding. β-hCG serum level was high (53 969 mIU/mL), and ultrasonography examination showed the presence of fluid filling the uterine cavity. The patient was then diagnosed with GTN, and hysterectomy was chosen as the treatment of choice. After the surgery, her β-hCG serum level gradually reverted back to normal. CONCLUSIONS: Invasive moles can develop less than 1 month after suction evacuation and curettage procedure for CHM. Serial β-hCG serum level evaluation according to the guideline should be performed to prevent late diagnosis, which could lead to the development of metastasis and worsen the prognosis. International Scientific Literature, Inc. 2021-06-15 /pmc/articles/PMC8216494/ /pubmed/34127641 http://dx.doi.org/10.12659/AJCR.931156 Text en © Am J Case Rep, 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Harsono, Ali Budi
Hidayat, Yudi Mulyana
Winarno, Gatot Nyarumenteng A.
Nisa, Aisyah Shofiatun
Alkaff, Firas Farisi
A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation
title A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation
title_full A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation
title_fullStr A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation
title_full_unstemmed A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation
title_short A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation
title_sort case of rapid transformation from hydatidiform mole to invasive mole: the importance of β-hcg (human chorionic gonadotropin) serum levels in follow-up evaluation
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216494/
https://www.ncbi.nlm.nih.gov/pubmed/34127641
http://dx.doi.org/10.12659/AJCR.931156
work_keys_str_mv AT harsonoalibudi acaseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT hidayatyudimulyana acaseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT winarnogatotnyarumentenga acaseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT nisaaisyahshofiatun acaseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT alkafffirasfarisi acaseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT harsonoalibudi caseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT hidayatyudimulyana caseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT winarnogatotnyarumentenga caseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT nisaaisyahshofiatun caseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation
AT alkafffirasfarisi caseofrapidtransformationfromhydatidiformmoletoinvasivemoletheimportanceofbhcghumanchorionicgonadotropinserumlevelsinfollowupevaluation